{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T20:28:59Z","timestamp":1771964939471,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,12,19]],"date-time":"2008-12-19T00:00:00Z","timestamp":1229644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00109-008-0423-2","type":"journal-article","created":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T09:01:00Z","timestamp":1229590860000},"page":"249-260","source":"Crossref","is-referenced-by-count":73,"title":["Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT\/GSK3\u03b2 signaling"],"prefix":"10.1007","volume":"87","author":[{"given":"Qizhu","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Difei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouyan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Qing","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Zhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,19]]},"reference":[{"key":"423_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2007.10.011","volume":"29","author":"C Palermo","year":"2008","unstructured":"Palermo C, Joyce JA (2008) Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci 29:22\u201328","journal-title":"Trends Pharmacol Sci"},{"key":"423_CR2","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1096\/fj.06-7924com","volume":"21","author":"SP Lutgens","year":"2007","unstructured":"Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S (2007) Cathepsin cysteine proteases in cardiovascular disease. FASEB J 21:3029\u20133041","journal-title":"FASEB J"},{"key":"423_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/138161207780162962","volume":"13","author":"O Vasiljeva","year":"2007","unstructured":"Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B (2007) Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 13:387\u2013403","journal-title":"Curr Pharm Des"},{"key":"423_CR4","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc1949","volume":"6","author":"MM Mohamed","year":"2006","unstructured":"Mohamed MM, Sloane BF (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6:764\u2013775","journal-title":"Nat Rev Cancer"},{"key":"423_CR5","first-page":"735","volume":"382","author":"T Reinheckel","year":"2001","unstructured":"Reinheckel T, Deussing J, Roth W, Peters C (2001) Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol Chem 382:735\u2013741","journal-title":"Biol Chem"},{"key":"423_CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1570-9639(03)00152-3","volume":"1649","author":"K Ohashi","year":"2003","unstructured":"Ohashi K, Naruto M, Nakaki T, Sano E (2003) Identification of interleukin-8 converting enzyme as cathepsin L. Biochim Biophys Acta 1649:30\u201339","journal-title":"Biochim Biophys Acta"},{"key":"423_CR7","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2337\/diabetes.52.9.2411","volume":"52","author":"X Huang","year":"2003","unstructured":"Huang X, Vaag A, Carlsson E, Ahr\u00e9n B, Groop L (2003) Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes. Diabetes 52:2411\u20132418","journal-title":"Diabetes"},{"key":"423_CR8","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI32022","volume":"117","author":"S Sever","year":"2007","unstructured":"Sever S, Altintas MM, Nankoe SR, M\u00f6ller CC, Ko D, Wei C, Henderson J, del Re EC, Hsing L, Erickson A, Cohen CD, Kretzler M, Kerjaschki D, Rudensky A, Nikolic B, Reiser J (2007) Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest 117:2095\u20132104","journal-title":"J Clin Invest"},{"key":"423_CR9","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/CIRCULATIONAHA.107.688523","volume":"115","author":"S Kitamoto","year":"2007","unstructured":"Kitamoto S, Sukhova GK, Sun J, Yang M, Libby P, Love V, Duramad P, Sun C, Zhang Y, Yang X, Peters C, Shi GP (2007) Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 115:2065\u20132075","journal-title":"Circulation"},{"key":"423_CR10","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1073\/pnas.092637699","volume":"99","author":"J Stypmann","year":"2002","unstructured":"Stypmann J, Gl\u00e4ser K, Roth W, Tobin DJ, Petermann I, Matthias R, M\u00f6nnig G, Haverkamp W, Breithardt G, Schmahl W, Peters C, Reinheckel T (2002) Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc Natl Acad Sci U S A 99:6234\u20136239","journal-title":"Proc Natl Acad Sci U S A"},{"key":"423_CR11","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1096\/fj.05-5517fje","volume":"20","author":"I Petermann","year":"2006","unstructured":"Petermann I, Mayer C, Stypmann J, Biniossek ML, Tobin DJ, Engelen MA, Dandekar T, Grune T, Schild L, Peters C, Reinheckel T (2006) Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. FASEB J 20:1266\u20131268","journal-title":"FASEB J"},{"key":"423_CR12","doi-asserted-by":"crossref","first-page":"37045","DOI":"10.1074\/jbc.M703447200","volume":"282","author":"D Spira","year":"2008","unstructured":"Spira D, Stypmann J, Tobin DJ, Petermann I, Mayer C, Hagemann S, Vasiljeva O, G\u00fcnther T, Sch\u00fcle R, Peters C, Reinheckel T (2008) Cell type-specific functions of the lysosomal protease cathepsin L in the heart. J Biol Chem 282:37045\u20133752","journal-title":"J Biol Chem"},{"key":"423_CR13","first-page":"879","volume":"118","author":"HL Li","year":"2008","unstructured":"Li HL, Liu C, de Couto G, Ouzounian M, Sun M, Wang AB, Huang Y, He CW, Shi Y, Chen X, Nghiem MP, Liu Y, Chen M, Dawood F, Fukuoka M, Maekawa Y, Zhang L, Leask A, Ghosh AK, Kirshenbaum LA, Liu PP (2008) Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 118:879\u2013893","journal-title":"J Clin Invest"},{"key":"423_CR14","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI29134","volume":"117","author":"SB Haudek","year":"2007","unstructured":"Haudek SB, Taffet GE, Schneider MD, Mann DL (2007) TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 117:2692\u20132701","journal-title":"J Clin Invest"},{"key":"423_CR15","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.freeradbiomed.2006.01.005","volume":"40","author":"HL Li","year":"2006","unstructured":"Li HL, Huang Y, Zhang CN, Williams GM, Liu DP, Liang CC (2006) Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med 40:1756\u20131775","journal-title":"Free Radic Biol Med"},{"key":"423_CR16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"key":"423_CR17","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1101\/gad.1492806","volume":"20","author":"I Shiojima","year":"2006","unstructured":"Shiojima I, Walsh K (2006) Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway. Genes Dev 20:3347\u20133365","journal-title":"Genes Dev"},{"key":"423_CR18","doi-asserted-by":"crossref","first-page":"32841","DOI":"10.1074\/jbc.M513087200","volume":"281","author":"B DeBosch","year":"2006","unstructured":"DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ (2006) Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 281:32841\u201332851","journal-title":"J Biol Chem"},{"key":"423_CR19","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1038\/sj.bjp.0707659","volume":"153","author":"PH Sugden","year":"2008","unstructured":"Sugden PH, Fuller SJ, Weiss SC, Clerk A (2008) Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 153:S137\u2013S153","journal-title":"Br J Pharmacol"},{"key":"423_CR20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","volume":"116","author":"Y Wang","year":"2007","unstructured":"Wang Y (2007) Mitogen-activated protein kinases in heart development and diseases. Circulation 116:1413\u20131423","journal-title":"Circulation"},{"key":"423_CR21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","volume":"63","author":"JD Molkentin","year":"2004","unstructured":"Molkentin JD (2004) Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467\u2013475","journal-title":"Cardiovasc Res"},{"key":"423_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cardiores.2006.07.012","volume":"74","author":"A Leask","year":"2007","unstructured":"Leask A (2007) TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 74:207\u2013212","journal-title":"Cardiovasc Res"},{"key":"423_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardiores.2005.04.012","volume":"67","author":"VP Empel Van","year":"2005","unstructured":"Van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ (2005) Myocyte apoptosis in heart failure. Cardiovasc Res 67:21\u201329","journal-title":"Cardiovasc Res"},{"key":"423_CR24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cardiores.2005.12.009","volume":"69","author":"S Rutschow","year":"2006","unstructured":"Rutschow S, Li J, Schultheiss HP, Pauschinger M (2006) Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovasc Res 69:646\u2013656","journal-title":"Cardiovasc Res"},{"issue":"6","key":"423_CR25","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/HYPERTENSIONAHA.106.085399","volume":"49","author":"HL Li","year":"2007","unstructured":"Li HL, She ZG, Li TB, Wang AB, Yang Q, Wei YS, Wang YG, Liu DP (2007) Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice. Hypertension. 49(6):1399\u20131408","journal-title":"Hypertension"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-008-0423-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-008-0423-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-008-0423-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:28:49Z","timestamp":1558585729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-008-0423-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,19]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1007\/s00109-008-0423-2","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,19]]}}}